A new cross-sectional study out of Bahrain has put a spotlight on the strengths and weaknesses of multiple sclerosis (MS) knowledge among the nation’s primary care physicians. While the surveyed doctors generally know the basics—demographics, causes, and symptoms of MS—there are significant gaps when it comes to diagnosing and managing relapses, as well as recommending the right treatment during flare-ups.
Researchers reached out to 428 primary care physicians working across Bahrain’s health centres, with 211 completing the knowledge questionnaire—a response rate of 49.3%. The findings were clear: over half correctly identified MS as an immune-mediated disorder targeting the central nervous system, and 67.3% understood that it affects women more frequently. Most also knew that people between 20 and 40 years old are at highest risk, and 60.2% recognized relapsing-remitting MS as the most common type.
Gaps in Relapse Recognition and Treatment
However, the study revealed some worrying gaps. Although 76.8% of physicians recognized that an MS relapse involves new or worsening neurological symptoms, only 33.7% knew these symptoms must persist for at least 24 hours to qualify as a relapse. Even fewer—just 44.5%—understood that relapses should be separated by at least 30 days. Perhaps most strikingly, only 41.2% correctly identified methylprednisolone 500–1000 mg as the recommended primary therapy for an MS flare-up.
It’s not just about academic knowledge, either. MS can have a devastating impact on patients’ lives, often robbing them of independence, affecting cognition, and leading to depression. Financially, it’s the second most costly chronic disease after heart failure, with annual direct and indirect costs per patient reaching $54,244—and for those with severe disability, over $100,000 a year.
The study found that doctors who had attended MS conferences, workshops, or had more exposure to MS patients scored higher on the knowledge assessment. The researchers concluded that while Bahraini primary care physicians have a solid foundational understanding, there’s a clear need for targeted educational initiatives—especially in areas like diagnosis, relapse care, and up-to-date treatment options. Closer collaboration between general practitioners and MS specialists could speed up accurate diagnoses and get patients the care they need, sooner.
